In a company note published earlier today, Jefferies & Company, Inc. reiterated its Buy rating for Amarin Corporation AMRN and raised its price target from $24.00 to $26.00.
Jefferies & Company went on to say “Yesterday, the patent office (PTO) posted unexpected positive office actions on three key patent applications based on MARINE: the core ‘889 application and two continuation applications ‘408 and '145. We believe these actions should lead to near-term issuance of these patents, which could provide AMR101 protection through 2030. We remain bullish on near-term approval of AMR101.”
Amarin Corporation closed yesterday at $13.16.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in